Evolva
Company

Last deal

$540.K

Amount

Grant

Stage

21.10.2022

Date

10

all rounds

$121.7M

Total amount

General

About Company
Evolva is a biotechnology company that creates innovative small molecule drugs and other compounds using synthetic biology.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2004

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company's proprietary technology platform allows them to create chemistries that mimic natural products without their disadvantages. Evolva discovers, develops, and commercializes ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. They use technology platforms like fermentation to provide products that promote health, wellbeing, and sensory enjoyment. With 55 employees from 15 nationalities, Evolva promotes an interdisciplinary and inclusive working environment. They operate in Switzerland and the United States, with Switzerland being their primary revenue source.
Contacts